Prognostic Accuracy of Transplant Clinicians Compared to Recipients of Allogeneic Hematopoietic Cell Transplantation Who Are Older, Medically Infirm, and/or Frail and Enrolled in an Ongoing Seamless Phase 2/3 Randomized Interventional Trial (ACE-BMT)
Elizabeth T. Loggers(University of Washington), Mohamed L. Sorror(University of Washington Medical Center), Ronald Sobecks(Cleveland Clinic), Reena Jayani(Vanderbilt University Medical Center), Michael W. Rabow, Kyle Neale(Cleveland Clinic), Laura Johnston(City Of Hope National Medical Center), James Fausto(University of Washington), Hassan B. Alkhateeb(Mayo Clinic), Rebecca L. Olin(University of California, San Francisco), Mei-Ean Yeow(Mayo Clinic in Arizona), Diana Martins-Welch(Hofstra University), Laura S. Rhee(Mayo Clinic in Arizona), Matthew Givens(Fred Hutch Cancer Center), Susan McInnes(Cleveland Clinic), Santiago Lopez(Hofstra University), Sara Martin(Vanderbilt University Medical Center), Rachel Cook(Oregon Health & Science University), Elisheva Newman(The Barbara Ann Karmanos Cancer Institute), Mark Juckett(UW Health University Hospital)
Cited by 0
Related Papers
Cancer-Related Fatigue, Version 2.2015
|Journal of the National Comprehensive Cancer Network|2015|951
Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2017|655
Geriatric Assessment–Driven Intervention (GAIN) on Chemotherapy-Related Toxic Effects in Older Adults With Cancer
|JAMA Oncology|2021|464
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|435